Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Theratechnologies receives patent protection for HIV drug
As previously announced, the product patent for GHRH analogues including tesamorelin, granted on January 19, 1999, expires in 2015. The new patent covering the methods of treatment provides
As previously announced, the product patent for GHRH analogues including tesamorelin, granted on January 19, 1999, expires in 2015. The new patent covering the methods of treatment provides
Mr. Nelson has served on Digirad’s board of directors since March 2004. He is currently president and CEO of Uptake Medical. Mr. Nelson said: “Based on my experience
SkinMedica said that the new Desonate (desonide) TwinPack contains two 60gm tubes of Desonate gel for greater coverage of affected areas during the cold-weather season when atopic dermatitis
The company will use the grant proceeds to conduct research that will allow for rapid labeling and purification of specific lineage restricted cells (LRCs) in cultures of differentiating
However, in tandem with this move, the company has also secured access to an incubator space facility in New Brunswick, New Jersey where intramural laboratory-based research will be
The patent covers the composition of matter for humanized, chimeric and human anti-CD74 antibodies, CD74 antibody fusion proteins, immunoconjugates, vaccines and bispecific antibodies that bind to CD74, the
Unigene and Shijiazhuang Pharmaceutical Group (SPG) plan to establish the SPG-Unigene Biotechnology Research Institute in China. The institute will continue ongoing registration activities for Unigene’s calcitonin products, develop
The study in 60 patients with uncontrolled hypertension demonstrated that SLx-2101 caused clinically significant reductions in blood pressure and was well-tolerated. The trial was designed to examine the
Former CEO Nicholas Teti, Jr will continue to serve as chairman of the board of directors and as a consultant to the company, but has resigned as president
While most pharmacological agents are employed to chemically signal cells to interrupt, reduce production or bind and regulate specific disease-causing proteins, this application of Cytogenix’s novel single-stranded DNA